Moreover, recent clinical studies suggested that SERPINA1 is also a promising anti-inflammatory therapeutic to treat obesity-associated insulin resistance, cystic fibrosis, and COVID-19.44 This evidence concerns the gene SERPINA1 and obesity disorder.